SEATTLE, WA, UNITED STATES, April 2, 2025 /EINPresswire.com/ — Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced that the U.S. Patent and Trademark Office has issued patent no. 12,263,077 titled “Vascular Grafts and Method for Preserving Patency of the Same”. This patent relates to Healionics’ STARgraft vascular graft, designed to provide a safer and more reliable means of bloodstream access for kidney failure patients needing dialysis.
Healionics Granted US Patent for STARgraft Technology
